Colorectal cancer screening tests: Pros and cons, and for whom?

Expert Review of Gastroenterology and Hepatology

Volumn 2, Issue 2, 2008, Pages 197-205

  Forbes, Geoffrey M ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cancer; Colonoscopy; Colorectal cancer; CT colonography; Fecal occult blood test; Flexible sigmoidoscopy; Screening

Indexed keywords

BISACODYL; MACROGOL; MAGNESIUM CITRATE; PICOSULFATE SODIUM;

ARTICLE; BARIUM ENEMA; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; CLINICAL PROTOCOL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; MASS SCREENING; OCCULT BLOOD; PATIENT SATISFACTION; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

COLORECTAL NEOPLASMS; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 55649115722     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/17474124.2.2.197     Document Type: Article

References (62)

1. Winawer S, Fletcher R, Rex D et al.. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 124(2), 544-560 (2003).
2. National Health and Medical Research Council. Clinical guidelines for the prevention, early detection and management of colorectal cancer. Canberra: National Health and Medical Research Council (2005).
3. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 328(19), 1365-1371 (1993).
4. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040), 1472-1477 (1996).
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult-blood test. Lancet 348(9040), 1467-1471 (1996).
6. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl Cancer Inst. 84(20), 1572-1575 (1992).
7. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-conttol study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 26(10), 653-657 (1992).
8. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N. Engl. J. Med. 343(3), 162-168 (2000).
9. Scott R, Edwards JT, Fritschi L, Foster NM, Mendelson RM, Forbes GM. Community based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am. J. Gastroent. 99(6), 1145-1151 (2004).
10. Betés M, Muñoz-Navas MA, Duque JM et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am. J. Gastroenterol. 98(12), 2648-2654 (2003).
11. Sung JJ, Chan FK, Leung WK et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 124(3), 608-614 (2003).
12. Regula J, Rupinski M, Kraszewska E et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N. Engl. J. Med. 355(18), 1863-1872 (2006).
13. Sosna J, Morrin MM, Kruskal JB, Lavin PT, Rosen MP, Raptopoulos V. CT colonography of colorectal polyps: a metaanalysis. Am. J. Roentgenol. 181(6), 1593-1598 (2003).
14. Edwards JT, Mendelson RM, Fritschi L et al. Colorectal neoplasia screening by virtual colonoscopy in average-risk asymptomatic subjects: a community based study. Radiology 230(2), 459-464 (2004).
15. Pickhardt PJ, Choi JR, Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N. Engl. J. Med. 349(23), 2191-2200 (2003).
16. Winawer SJ, Stewart ET, Zauber AG et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N. Engl. J. Med. 342(24), 1766-1772 (2000).
17. Young GP, St John DJ, Winawer SJ, Rozen P; WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am. J. Gastroenterol. 97(10), 2499-2507 (2002).
18. Turner GB, Chin MW, Foster NM, Emery J, Forbes GM. Attitudes of Western Australian general practitioners to colorectal cancer screening. Med. J. Aust. 185(4), 237 (2006).
19. Corbett M, Chambers SL, Shadbolt B, Hillman LC, Tanpin D. Colonoscopy screening for colorectal cancer: the outcomes of two recruitment methods. Med. J. Aust. 181(8), 423-427 (2004).
20. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359 (9314), 1291-1300 (2002).
21. Bowel cancer screening pilot monitoring and evaluation committee. Australia's Bowel Cancer Screening Pilot and Beyond: Final Evaluation Report. Canberra: National Health and Medical Research Council (2005).
22. AGA Clinical Practice and Economics Committee. Position of the American Gastroenterological Association (AGA) institute on computed tomographic colonography. Gastroenterology 131(5), 1627-1628 (2006).
23. Halligan S, Atkin W. Unbiased studies are required before virtual colonoscopy can be dismissed. Lancet 365(9456), 275-276 (2005).
24. Ferrucci JT. Colon cancer screening with virtual colonoscopy: promise, polyps, politics. Am. J. Roentgenol. 177(5), 975-988 (2001).
25. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 329(7458), 133-138 (2004).
26. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am. J. Gastroenterol. 98(9), 2082-2091 (2003).
27. Liebermnan DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 109(6), 781-790 (1995).
28. Sonnenberg A, Delco F, Inadomi JM. Cost effectiveness in screening for colorectal cancer. Ann. Int. Med. 133(8), 573-584 (2000).
29. Vernon SW. Participation in colorectal cancer screening: a review. J. Natl Cancer Inst. 89(19), 1406-1422 (1997).
30. The Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med. J. Aust. 184(11), 546-550 (2006).
31. Allison JE, Sakoda LC, Levin TR et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J. Natl Cancer Inst. 99(19), 1462-1470 (2007).
32. Levi Z, Rosen R Hazazi R et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann. Int. Med. 146(4), 244-255 (2007).
33. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N. Engl. J. Med. 351(26), 2704-2714 (2004).
34. Woolf SH. A smarter strategy? Reflections on fecal DNA screening for colorectal cancer. N. Engl. J. Med. 351(26), 2755-2758 (2004).
35. Nadel MR, Shapiro JA, Klabunde CN et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann. Intern. Med. 142(2), 86-94 (2005).
36. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann. Intern. Med. 142(2), 81-85 (2005).
37. Medicare Benefits Schedule Book. Canberra: Australian Government Department of Health and Ageing, 2007.
38. Lewis JD, Ng K, Hung KE et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch. Intern. Med. 163(4), 413-420 (2003).
39. Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345(8), 555-560 (2001).
40. Levin TR, Conell C, Shapiro JA, Chazan SG, Nadel MR, Selby JV. Complications of screening flexible sigmoidoscopy. Gastroenterology 123(6), 1786-1792 (2002).
41. Viiala CH, Zimmerman M, Cullen DJ, Hoffman NE. Complication rates of colonoscopy in an Australian teaching hospital environment. Intern. Med. J. 33(8), 355-359 (2003).
42. Farraye FA, Horton K, Hersey H, Troka Y, Heeren T, Provenzale D. Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Am. J. Gastroenterol. 99(6), 1074-1080 (2004).
43. Collett JA, Olynyk JK, Platell CF. Flexible sigmoidoscopy screening for colorectal cancer in average-risk people: update of a community-based project. Med. J. Aust. 173(9), 463-466 (2000).
44. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. Grading of distal colorectal adenomas as predictors for proximal colonic neoplasia and choice of endoscope in population screening: experience from the Norwegian Colorectal Cancer Prevention study (NORCCAP). Gut 52(3), 398-403 (2003).
45. Rex DK, Cutler CS, Lemmel GT. Colonoscopic miss rates of adenomas determined by back to back colonoscopies. Gastroenterology 112(1), 292-294 (1997).
46. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132(1), 96-102 (2007).
47. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N. Engl. J. Med. 355(24), 2533-2541 (2006).
48. Rex DK. Maximising detection of adenomas and cancers during colonoscopy. Am. J. Gastroenterol. 101(12), 2866-2877 (2006).
49. Hoff G, Byetthauer M, Huppertz-Hauss G et al. The Norwegian Gastronet project: Continuous quality improvement of colonoscopy in 14 Norwegian centres. Scand. J. Gastroenterol. 41(4), 481-487 (2006).
50. Bowles CJ, Leicester R, Romaya C, Swarbrick E, Williams CB, Epstein O. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53(2), 277-283 (2004).
51. Palmer KR, Morris AI. A snapshot of colonoscopy practice in England: stimulus for improvement. Gut 53(2), 163-165 (2004).
52. Bampton PA, Sandford JJ, Young GP. Achieving long-term compliance with colonoscopic surveillance guidelines for patients at increased risk of colorectal cancer in Australia. Int. J. Clin. Pract. 61, 510-513 (2007).
53. Seow CH, Ee HC, Willson AB, Yusoff IE. Repeat colonoscopy has a low yield even in symptomatic subjects. Gastrointest. Endosc. 64(6), 941-947 (2006).
54. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M. Does a negative screening colononscopy ever need to be repeated? Gut 55(8), 1145-1150 (2006)
55. Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch. Intern. Med. 162(2), 163-168 (2002).
56. Rosman AS, Korten MA. Meta-analysis comparing CT colonography, air contrast barium enema and colonoscopy. Am. J. Med. 120(3), 203-210 (2007).
57. Chin M, Mendelson R, Edwards J, Foster N, Forbes G. Computed tomographic colonography: prevalence, nature, and clinical significance of extracolonic findings in a community screening program. Am. J. Gastroenterol. 100(12), 2771-2776 (2005).
58. Nicholson FB, Barro JL, Bartram CI et al. The role of CT colonography in colorectal cancer screening. Am. J. Gastroenterol. 100(10), 2315-2323 (2005).
59. Kinner S, Kuehle CA, Langhorst J et al. MR colonography vs optical colonoscopy: comparison of patients acceptance in a screening population. Eur. J. Radiol. 17(9), 2286-2293 (2007).
60. ASGE Technology Committee, Wong Kee Song LM, Adler LG et al. Chromoendoscopy. Gastrointest. Endosc. 66(4), 639-649 (2007).
61. Tran K. Capsule colonoscopy: PillCam Colon. Issues Emerg. Health Technol. 106, 1-4 (2007).
62. Brotherstone H, Vance M, Edwards R et al.. Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study. J. Med. Screen. 142 (2), 767-780 (2007).